Literature DB >> 20160658

Postvaccination thrombocytopenia in Canada.

Laura J Sauvé1, Julie Bettinger, David Scheifele, Scott Halperin, Wendy Vaudry, Barbara Law.   

Abstract

Active surveillance data from 12 Canadian tertiary-care hospitals on children hospitalized with postvaccination thrombocytopenia were analyzed. Since 1992, there have been 107 cases reported; while 96% of the children were symptomatic, only 2 had severe bleeding. With treatment, 28 children (26%) had normal platelet counts on discharge from hospital and 93% had documented recovery within 3 months.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20160658     DOI： 10.1097/INF.0b013e3181d2bb45

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.

Authors:  J A Bettinger; S A Halperin; W Vaudry; B J Law; D W Scheifele
Journal:  Can Commun Dis Rep       Date:  2014-12-04

Review 3.  Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review.

Authors:  Takuto Shonai; Fumihiko Kimura; Junichi Watanabe
Journal:  Intern Med       Date:  2022-03-19       Impact factor: 1.282

4.  Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia.

Authors:  Karina A Top; Kristine Macartney; Julie A Bettinger; Ben Tan; Christopher C Blyth; Helen S Marshall; Wendy Vaudry; Scott A Halperin; Peter McIntyre
Journal:  Euro Surveill       Date:  2020-06

5.  Demonstration of background rates of three conditions of interest for vaccine safety surveillance.

Authors:  Anne E Wormsbecker; Caitlin Johnson; Laura Bourns; Tara Harris; Natasha S Crowcroft; Shelley L Deeks
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.